BCRX
BIOCRYST PHARMACEUTICALS INC
NASDAQ · Healthcare · Biotechnology · US
$8.07
+3.59%Forward multiples
Based on analyst estimates
- P/E forward
- 12.81x
- P/E 2026E
- —
- P/E 2027E
- 13.88x
- P/E 2028E
- 12.39x
- P/S forward
- 2.85x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -4.54x
- Price / sales
- 2.19x
- Price / cash flow
- 5.73x
Enterprise value
- Enterprise value
- $2.1B
- EV / sales
- 2.25x
- EV / EBITDA
- -7.00x
- EV / EBIT
- -6.77x
- Market cap
- $2.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026